共 50 条
- [21] THROMBOXANE-B2 AND 6-KETO PGF 1-ALPHA RELEASE INTO CORONARY VENOUS-BLOOD - EFFECT OF CORONARY-ARTERY OCCLUSION [J]. JOURNAL OF PHYSIOLOGY-LONDON, 1981, 316 (JUL): : P12 - P12
- [24] THE IMPERMEABILITY OF THE BASIC CELL-MEMBRANE TO THROMBOXANE-B2, PROSTACYCLIN AND 6-KETO-PGF-1ALPHA [J]. PROSTAGLANDINS, 1981, 21 (01): : 133 - 142
- [26] PLASMA 6-KETO-PGF1-ALPHA, THROMBOXANE-B2 AND PGE2 DURING DIABETIC-KETOACIDOSIS [J]. PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS, 1990, 41 (04): : 285 - 285
- [28] PLASMA 6-KETO-PGF1-ALPHA, THROMBOXANE-B2 AND PGE2 DURING DIABETIC-KETOACIDOSIS [J]. PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS, 1990, 40 (01): : 39 - 43
- [29] URINARY 6-KETOPROSTAGLANDIN-F1 (6KF1-ALPHA) AND THROMBOXANE-B2 (TXB2) EXCRETION IN OBSTRUCTIVE UROPATHY IN CHILDHOOD [J]. AUSTRALIAN PAEDIATRIC JOURNAL, 1985, 21 (04): : 303 - 303
- [30] REBOUND ELEVATION IN URINARY THROMBOXANE-B2 AND 6-KETO-PGF1-ALPHA-EXCRETION AFTER ASPIRIN WITHDRAWAL [J]. ADVANCES IN PROSTAGLANDIN THROMBOXANE AND LEUKOTRIENE RESEARCH, 1991, 21 : 157 - 160